DIO and paclitaxel encapsulated in lipid nanoparticles

We can offer a discount on bulk orders. Please contact our sales team for further inquiry.

Product Infomation

Product Name	DIO and paclitaxel encapsulated in lipid nanoparticles
Catalog Number	LNP-071
Size	10 mg; 20 mg; 50 mg
Alias	LNP@DIO-PTX; Lipid nanoparticles encapsulating 1, 1'-dioctyl-3, 3, 3', 3'-tetramethylindocyanine perchlorate-paclitaxel
Appearance	Dispersion
Solubility	Dispersed in water or PBS buffer
Description	LNP@DIO-PTX is a constructed nanocomplex that encapsulates 1, 1′-dioctyl-3, 3, 3′, 3′-tetramethylindocyanine perchlorate-labeled paclitaxel inside lipid nanoparticles. Lipid nanoparticles are mainly composed of ionizable cationic phospholipids, cholesterol, auxiliary phospholipids and polyethylene glycol modified phospholipids. Under physiological pH conditions, ionizable cationic phospholipids are neutral, protonated and positively charged in acidic environments such as endosomes, and can be closely combined with negatively charged or polar DIO-PTX through electrostatic interactions, hydrophobic interactions, etc.
Applications	Preparation of lipid nanoparticles
Storage	2-8°C, protected from light
Purity	95%+
Shelf Life	1 Year
Shipping Condition	Low temperature transport

Online Inquiry